Vaccine News and Research

Latest Vaccine News and Research

Pfizer reports that Prevenar 13 Phase 3 study meets all primary, secondary objectives

Pfizer Inc. presented today the results from a Phase 3 study investigating immunogenicity, tolerability and safety of Prevenar 13 (Pneumococcal polysaccharide conjugate vaccine [13-valent, adsorbed]) in adults 18 to 49 years of age.

From Pfizer, Inc. 29 Apr 2013

First Edition: April 26, 2013

Today's headlines include reports that some Democratic senators have concerns about the health law's roll out as well as other news about the measure's implementation.

26 Apr 2013

Researchers call H7N9 bird flu strain 'one of the most lethal'; first case outside China reported by Taiwan

Chinese scientists have confirmed for the first time that a new strain of bird flu that has killed 23 people in China has been transmitted to humans from chickens.

26 Apr 2013

Calcipotriol drug offers a potential treatment option for fibrotic diseases

Liver fibrosis results from an excessive accumulation of tough, fibrous scar tissue and occurs in most types of chronic liver diseases. In industrialized countries, the main causes of liver injury leading to fibrosis include chronic hepatitis virus infection, excess alcohol consumption and, increasingly, nonalcoholic steatohepatitis (NASH).

26 Apr 2013

Thermo Fisher Scientific brings several innovations in bioprocessing technologies and systems

Thermo Fisher Scientific Inc., the world leader in serving science, today debuted several innovations in bioprocessing technologies and systems that address the evolving requirements of drug discovery and production for global biopharmaceutical and pharmaceutical manufacturers.

From Thermo Fisher Scientific Inc. 26 Apr 2013

New Thermo Scientific Aegis5-14 film for cell culture and bioprocessing applications

Thermo Fisher Scientific Inc., the world leader in serving science, today introduced the Thermo Scientific Aegis5-14 Film, the company's new advanced single-use film that is ideal for the most demanding cell culture and bioprocessing applications in drug development and biomanufacturing.

From Thermo Fisher Scientific Inc. 26 Apr 2013

Opinion pieces published in recognition of World Malaria Day

Wednesday is World Malaria Day, observed annually on April 25. This year's theme is "Invest in the future: defeat malaria." The following is a summary of opinion pieces published in recognition of the day.

26 Apr 2013

New research collaboration may help in developing TB vaccine for bovines and humans

Scientists at The University of Nottingham are studying whether harmful bacteria found in cattle could be harnessed to protect livestock from the devastating disease bovine tuberculosis (TB).

26 Apr 2013

Immudex signs agreement to provide MHC-peptide multimer and Elispot proficiency panel services

Immudex has entered into a strategic agreement with the US Cancer Immunotherapy Consortium (CIC) of the Cancer Research Institute, and the European Association for Cancer Immunotherapy (CIMT), under which Immudex will provide MHC-peptide multimer and Elispot proficiency panel services worldwide.

26 Apr 2013

Bill Gates seeks additional $1.5B in donations for polio eradication efforts

Bill Gates, co-chair of the Bill & Melinda Gates Foundation, "is seeking a further $1.5 billion in donations to wipe out polio by 2018 and make it the first infectious disease eradicated since smallpox was wiped from the planet in 1979".

26 Apr 2013

NIAID findings provide structural basis for developing RSV vaccine

An atomic-level snapshot of a respiratory syncytial virus (RSV) protein bound to a human antibody represents a leap toward developing a vaccine for a common-and sometimes very serious-childhood disease.

26 Apr 2013

New strain of bird flu poses pandemic threat

The World Health Organization (WHO) is calling the new strain of H7H9 influenza virus "lethal" and The University of Kansas Hospital is preparing now for any potential cases.

26 Apr 2013

Financial Times publishes special report on malaria

The Financial Times has published a special report (.pdf) on malaria featuring articles examining issues including prevention, treatment and research and development (R&D).

26 Apr 2013

H7N9 flu virus found to transmit from birds to humans but not person-to-person

Scientists in China have confirmed for the first time that the influenza A H7N9 virus has transmitted from birds—specifically, chicken at a wet poultry market—to humans, according to an Article published Online First in The Lancet.

25 Apr 2013

Leuphana University Lueneburg project to study challenges, opportunities of progressive ageing

Leuphana University Lueneburg will apply for an EU Innovation Project, with an investment volume of up to EUR 1.6 billion - Big Data revolution in Healthcare through focused European collaboration in the most promising application areas - Strong partnerships with the University Medical Center Goettingen and the University of Zurich as well as the Republic of Malta, Sclavo Vaccines Association of Italy and ICHOM, among others.

25 Apr 2013

GPEI presents comprehensive six-year polio eradication plan at Global Vaccine Summit

Today, at the Global Vaccine Summit, the Global Polio Eradication Initiative presented a comprehensive six-year plan, the first plan to eradicate all types of polio disease – both wild poliovirus and vaccine-derived cases – simultaneously.

25 Apr 2013

Three steps to eliminating NTDs

In a post on the PLoS "Speaking of Medicine" blog, PLoS Neglected Tropical Diseases (NTDs) editor-in-chief Peter Hotez, dean of the National School of Tropical Medicine at Baylor College of Medicine and president of the Sabin Vaccine Institute and Texas Children's Hospital Center for Vaccine Development, reviews progress being made toward the elimination of NTDs through mass drug administration and other efforts.

25 Apr 2013

Donations made, agreements signed to fight polio in advance of Global Vaccine Summit

Hundreds of international health experts and leaders from the public and private sectors are gathered in Abu Dhabi Wednesday for the beginning of the first Global Vaccine Summit, which "is expected to place special emphasis on polio eradication," Gulf News reports (Zaman, 4/23).

25 Apr 2013

Phase I/II data on Baxter's Lyme disease candidate vaccine presented at NFID conference

Baxter International Inc. today announced Phase I/II data evaluating the safety and immunogenicity of its investigational Lyme disease candidate vaccine during the National Foundation for Infectious Diseases 16th Annual Conference on Vaccine Research in Baltimore, Md.

From Baxter International Inc. 25 Apr 2013

University of Guelph researchers develop carbohydrate-based vaccine against gut bug

A first-ever vaccine created by University of Guelph researchers for gut bacteria common in autistic children may also help control some autism symptoms.

25 Apr 2013

Vaccine News and Research

Latest Vaccine News and Research

Pfizer reports that Prevenar 13 Phase 3 study meets all primary, secondary objectives

First Edition: April 26, 2013

Researchers call H7N9 bird flu strain 'one of the most lethal'; first case outside China reported by Taiwan

Calcipotriol drug offers a potential treatment option for fibrotic diseases

Thermo Fisher Scientific brings several innovations in bioprocessing technologies and systems

New Thermo Scientific Aegis5-14 film for cell culture and bioprocessing applications

Opinion pieces published in recognition of World Malaria Day

New research collaboration may help in developing TB vaccine for bovines and humans

Immudex signs agreement to provide MHC-peptide multimer and Elispot proficiency panel services

Bill Gates seeks additional $1.5B in donations for polio eradication efforts

NIAID findings provide structural basis for developing RSV vaccine

New strain of bird flu poses pandemic threat

Financial Times publishes special report on malaria

H7N9 flu virus found to transmit from birds to humans but not person-to-person

Leuphana University Lueneburg project to study challenges, opportunities of progressive ageing

GPEI presents comprehensive six-year polio eradication plan at Global Vaccine Summit

Three steps to eliminating NTDs

Donations made, agreements signed to fight polio in advance of Global Vaccine Summit

Phase I/II data on Baxter's Lyme disease candidate vaccine presented at NFID conference

University of Guelph researchers develop carbohydrate-based vaccine against gut bug

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Vaccine News and Research

Latest Vaccine News and Research

Event guide: 3rd mRNA Process Development & Manufacturing Europe eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in